Currently out of the existing stock ratings of Tessa Romero, 35 are a BUY (68.63%), 13 are a HOLD (25.49%), 3 are a SELL (5.88%).

Tessa Romero

Work Performance Price Targets & Ratings Chart

Analyst Tessa Romero works at JPMORGAN with a stock forecast success ratio of 50.96% fulfilled within 108.46 days on average.

Tessa Romero’s has documented 98 price targets and ratings displayed on 13 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ACAD, ACADIA Pharmaceuticals at 25-Mar-2024.

Wall Street Analyst Tessa Romero

Analyst best performing recommendations are on GBT (GLOBAL BLOOD THERAPEUTICS).
The best stock recommendation documented was for BHVN (BIOHAVEN PHARMACEUTICAL HOLDING CO LTD) at 5/17/2023. The price target of $21 was fulfilled within 16 days with a profit of $6.88 (48.73%) receiving and performance score of 30.45.

Average potential price target upside

EWTX Edgewise Therapeutics GBT Global Blood Therapeutics ORTX Orchard Therapeutics PLC ATRA Atara Biotherapeutics RIGL Rigel Pharmaceuticals SRRK Scholar Rock Holding Corp YMAB Y mAbs Therapeutics CYTK Cytokinetics XENE Xenon Pharmaceuticals ACAD ACADIA Pharmaceuticals BHVN Biohaven Pharmaceutical Holding Co Ltd AGIO Agios Pharm DYN Dyne Therapeutics 

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

23

$5.04 (28.06%)

27

4 months 18 days ago

0/5 (0%)

$17.49 (317.42%)

Buy

25

$7.04 (39.20%)

24

8 months 27 days ago

0/7 (0%)

$17.25 (222.58%)

Sell

5

$-12.96 (-72.16%)

1 years 7 months 3 days ago

2/3 (66.67%)

$-5.2 (-50.98%)

69

Buy

30

$12.04 (67.04%)

34

1 years 10 months 16 days ago

0/2 (0%)

$22.53 (301.61%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Tessa Romero is most bullish on?

Potential upside of $6.8 has been obtained for ACAD (ACADIA PHARMACEUTICALS)

Which stock is Tessa Romero is most reserved on?

Potential downside of -$1.02 has been obtained for BHVN (BIOHAVEN PHARMACEUTICAL HOLDING CO LTD)

What Year was the first public recommendation made by Tessa Romero?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?